$PIII·8-K

P3 Health Partners Inc. · Jul 6, 5:02 PM ET

Compare

P3 Health Partners Inc. 8-K

Research Summary

AI-generated summary

Updated

P3 Health Partners Announces Amendment to Repurchase Note, Extends Maturity

What Happened P3 Health Partners Inc. (through wholly owned subsidiary P3 Health Group, LLC) filed an 8-K (Item 1.01) disclosing a Second Amendment to a Repurchase Promissory Note with IHC Health Services, Inc. dated June 30, 2026. The amendment extends the note’s maturity date to September 30, 2028 and provides that, from June 30, 2026, the note will accrue payment-in-kind (PIK) interest at 14.0% per annum. The underlying note was originally dated June 28, 2019 and had been previously amended on November 19, 2020; all other terms remain unchanged.

Key Details

  • Parties: P3 Health Group, LLC (borrower; wholly owned subsidiary) and IHC Health Services, Inc. (holder).
  • Amendment date: June 30, 2026; 8-K filed July 6, 2026 and signed by CFO Leif Pedersen.
  • Maturity: Extended to September 30, 2028.
  • Interest: 14.0% per year, accruing as PIK interest starting June 30, 2026 (interest is added to the debt principal rather than paid in cash).

Why It Matters This filing affects P3 Health’s debt profile and near-term cash flow obligations: switching the note to 14% PIK interest reduces immediate cash interest payments (interest accrues to principal) but increases the total indebtedness over time. Investors should note the extended maturity and higher effective borrowing cost, which can influence leverage metrics and future cash requirements. The amendment is a material financing development reported under Item 1.01 of the 8-K.

Loading document...